Gene · 6582
Papers2,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Docking and ADME-TOX Profiling of Moringa oleifera Constituents against SARS-CoV-2. | Adv Respir Med | 2023 | 37987297 | PubTator, text mining | PubMed |
| Increased OCT3 Expression in Adipose Tissue With Aging: Implications for Catecholamine and Lipid Turnover and Insulin Resistance in Women. | Endocrinology | 2023 | 37972266 | PubTator, text mining | PubMed |
| Stereoselective Inhibition of High- and Low-Affinity Organic Cation Transporters. | Mol Pharm | 2023 | 37962560 | PubTator, text mining | PubMed |
Synthesis of Tetracyclic Spirooxindolepyrrolidine-Engrafted Hydantoin Scaffolds: Crystallographic Analysis, Molecular Docking Studies and Evaluation of Their Antimicrobial, Anti-Inflammatory and Analgesic Activities. | Molecules | 2023 | 37959862 | PubTator, text mining | PubMed |
| Space medicine: Hunting for pharmacologist's guide in dealing with drugs in microgravity. | Indian J Pharmacol | 2023 | 37929405 | PubTator, text mining | PubMed |
| Patients with primary carnitine deficiency treated with L-carnitine are alive and doing well-A 10-year follow-up in the Faroe Islands. | JIMD Rep | 2023 | 37927485 | PubTator, text mining | PubMed |
| Genetic preservation of SLC22A3 in the Admixed and Xhosa populations living in the Western Cape. | Mol Biol Rep | 2023 | 37924453 | PubTator, text mining | PubMed |
| Efficacy and safety profiles of dolutegravir plus lamivudine vs . bictegravir/emtricitabine/tenofovir alafenamide in therapy-naïve adults with HIV-1. | Chin Med J (Engl) | 2023 | 37914678 | PubTator, text mining | PubMed |
| Uptake Transporters at the Blood-Brain Barrier and Their Role in Brain Drug Disposition. | Pharmaceutics | 2023 | 37896233 | PubTator, text mining | PubMed |
| Computational Discovery of Marine Molecules of the Cyclopeptide Family with Therapeutic Potential. | Pharmaceuticals (Basel) | 2023 | 37895848 | PubTator, text mining | PubMed |
| Renal Organic Anion Transporters 1 and 3 In Vitro: Gone but Not Forgotten. | Int J Mol Sci | 2023 | 37895098 | PubTator, text mining | PubMed |
| Identification of cuproptosis-related gene SLC31A1 and upstream LncRNA-miRNA regulatory axis in breast cancer. | Sci Rep | 2023 | 37884650 | PubTator, text mining | PubMed |
| Mechanistic inhibition of gastric cancer-associated bacteria Helicobacter pylori by selected phytocompounds: A new cutting-edge computational approach. | Heliyon | 2023 | 37876433 | PubTator, text mining | PubMed |
| Interaction of amisulpride with GLUT1 at the blood-brain barrier. Relevance to Alzheimer's disease. | PLoS One | 2023 | 37874822 | PubTator, text mining | PubMed |
| Anti-cancer targets and molecular mechanisms of formononetin in treating osteosarcoma based on network pharmacology. | Aging (Albany NY) | 2023 | 37870753 | PubTator, text mining | PubMed |
| Unveiling the Anti-Cancer Potential of Onoceranoid Triterpenes from Lansium domesticum Corr. cv. kokosan: An In Silico Study against Estrogen Receptor Alpha. | Int J Mol Sci | 2023 | 37834479 | PubTator, text mining | PubMed |
| Oxidative Damage as a Fundament of Systemic Toxicities Induced by Cisplatin-The Crucial Limitation or Potential Therapeutic Target? | Int J Mol Sci | 2023 | 37834021 | PubTator, text mining | PubMed |
| Structural basis of promiscuous substrate transport by Organic Cation Transporter 1. | Nat Commun | 2023 | 37821493 | PubTator, text mining | PubMed |
| Risk factor analysis for cisplatin-induced nephrotoxicity with the short hydration method in diabetic patients. | Sci Rep | 2023 | 37816823 | PubTator, text mining | PubMed |
Chemico-pharmacological and computational studies of Ophiorrhiza fasciculata D. Don and Psychotria silhetensis Hook. f. focusing cytotoxic, thrombolytic, anti-inflammatory, antioxidant, and antibacterial properties. | Heliyon | 2023 | 37809757 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6582/papers?page=9